Literature DB >> 9608332

The effects of estrogen on osteoarthritis.

D T Felson1, M C Nevitt.   

Abstract

The prevalence of osteoarthritis is higher in women than men, and in women it increases dramatically in the years after menopause. These observations and others reporting a painful form of hand osteoarthritis after the menopause suggest that loss of estrogen at the time of menopause increases a woman's risk of getting osteoarthritis. This article reviews biologic evidence for hormone sensitivity of cartilage, animal studies testing the effect of estrogen on the joints of ovariectomized animals, and human epidemiologic and clinical studies evaluating endogenous estrogen levels and estrogen replacement therapy and their relation to the occurrence of osteoarthritis. Overall the evidence for a role of estrogen in osteoarthritis is conflicting. Epidemiologic studies of women who take estrogen replacement therapy, however, consistently report that these women have a lower prevalence of osteoarthritis than women not taking estrogen, suggesting a possible therapeutic role for estrogen in osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9608332     DOI: 10.1097/00002281-199805000-00019

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  27 in total

1.  Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis.

Authors:  T Miyazaki; M Wada; H Kawahara; M Sato; H Baba; S Shimada
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  History and current status of osteoarthritis in the population.

Authors:  W Watson Buchanan; Walter F Kean; Robert Kean
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

3.  Femoral Neck External Size but not aBMD Predicts Structural and Mass Changes for Women Transitioning Through Menopause.

Authors:  Karl J Jepsen; Andrew Kozminski; Erin Mr Bigelow; Stephen H Schlecht; Robert W Goulet; Sioban D Harlow; Jane A Cauley; Carrie Karvonen-Gutierrez
Journal:  J Bone Miner Res       Date:  2017-01-30       Impact factor: 6.741

4.  Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis.

Authors:  W Gao; C Zeng; D Cai; B Liu; Y Li; X Wen; Y Chen
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

5.  Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.

Authors:  Yun Jong Lee; Eun Bong Lee; Young Ee Kwon; Jung Jin Lee; Woo Shin Cho; Hyun A Kim; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2003-04-09       Impact factor: 2.631

6.  Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.

Authors:  H J Lehmann; U Mouritzen; S Christgau; P A C Cloos; C Christiansen
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 7.  TMJ disorders: future innovations in diagnostics and therapeutics.

Authors:  Sunil Wadhwa; Sunil Kapila
Journal:  J Dent Educ       Date:  2008-08       Impact factor: 2.264

8.  The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.

Authors:  Anne-Christine Bay-Jensen; Nadine C B Tabassi; Lene V Sondergaard; Thomas L Andersen; Frederik Dagnaes-Hansen; Patrick Garnero; Moustapha Kassem; Jean-Marie Delaissé
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

9.  An investigation of risk factors for symptomatic osteoarthritis of the knee in women using a life course approach.

Authors:  J Dawson; E Juszczak; M Thorogood; S-A Marks; C Dodd; R Fitzpatrick
Journal:  J Epidemiol Community Health       Date:  2003-10       Impact factor: 3.710

Review 10.  Osteoarthritis associated with estrogen deficiency.

Authors:  Jorge A Roman-Blas; Santos Castañeda; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Res Ther       Date:  2009-09-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.